Bavarian Nordic to Host Full Year 2018 Results Conference Call

NEXT STORY
Amphera Recruits First Patients to Pivotal Phase II/III study of MesoPher to Treat Pleural Mesothelioma
PREV STORY
Oasmia announces a prospectus regarding admission to trading of new shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Junshi Biosciences and Immorna Announce Joint Venture to Develop Innovative Self-Replicating and Conventional mRNA Therapeutics and Vaccines

author_avatar
NASDAQ Market News

Global Patient Engagement Solutions Market Will Grow Over USD 48.24 Billion By 2025: Zion Market Research

author_avatar
NASDAQ Market News

The global molecular diagnostics market was valued at USD 7,854.45 million in 2018, and is estimated to be valued at USD 13,340.35 million by 2024, while witnessing a CAGR of 9.23% during the forecast period, 2019

author_avatar
NASDAQ Market News